Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzymotec Ltd (NASDAQ:ENZY)

8.94
Delayed Data
As of 11:39am ET
 -0.39 / -4.18%
Today’s Change
5.38
Today|||52-Week Range
10.83
-8.78%
Year-to-Date
No recent news for Enzymotec Ltd.

Today’s Trading

Previous close9.33
Today’s open9.28
Day’s range8.82 - 9.38
Volume5,679
Average volume (3 months)40,308
Market cap$210.5M
Dividend yield--
Data as of 11:39am ET, 02/11/2016

Growth & Valuation

Earnings growth (last year)-76.16%
Earnings growth (this year)+5.88%
Earnings growth (next 5 years)+33.83%
Revenue growth (last year)-27.51%
P/E ratio--
Price/Sales3.76
Price/Book1.64

Competitors

 Today’s
change
Today’s
% change
RXDXIgnyta Inc-0.36-5.03%
EDGEEdge Therapeutics In...-0.59-7.98%
BTXBioTime Inc+0.02+1.18%
CBMGCellular Biomedicine...+0.03+0.17%
Data as of 12:55pm ET, 02/11/2016

Financials

Next reporting dateFebruary 17, 2016
EPS forecast (this quarter)$0.10
Annual revenue (last year)$47.1M
Annual profit (last year)$7.8M
Net profit margin16.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ariel Katz
Vice President-
Operations
Yariv Gratz
Corporate headquarters
Migdal HaEmeq, Hazafon

Forecasts

Partner Offers